Background Patients with SLE experience distressing fibromyalgia-like symptoms of fatigue,
widespread pain, mood disturbance, and brain fog that negatively impact quality of life and …

Background The Type 1 & 2 SLE Model was developed to better explain the signs,
symptoms, and management goals of systemic lupus erythematosus (SLE) to patients. We …

Background We have proposed a new model that divides SLE manifestations into Type 1
(objective signs of inflammation) and Type 2 (generalized pain and fatigue not clearly due to …

Background: The purpose of this exploratory study was threefold, ie, to clarify the unique
psychosocial challenges facing those living with systemic lupus erythematosus (SLE), to …

Objective This study explored challenges that patients with systemic lupus erythematosus
(SLE) and childhood-onset SLE (cSLE) face to identify modifiable influences and coping …

Objective In the new Type 1 & 2 model for systemic lupus erythematosus (SLE), Type 1 SLE
represents classic inflammatory manifestations, such as arthritis, while Type 2 SLE …

Although challenging, developing evidence-based approaches to an early and accurate
diagnosis of systemic lupus erythematosus is a key approach to preventing disease and …

Objective. Managing juvenile-onset systemic lupus erythematosus (SLE) is particularly
challenging. The disease may be severe, adolescent patients have complex medical and …

Background The physician global assessment (PGA) is a 3-point visual analog scale
assessing lupus disease activity. We implemented a Type II PGA to assess what we have …

Background: Systemic lupus erythematosus (SLE) is a complex and heterogenous
autoimmune disease characterised by periods of worsening symptoms, known as flares …